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Abstract
Background: Canine angiostrongylosis, a gastropod-borne helminthic infection, is increasingly being described in North
America and is now reported in many European countries. In dogs, Angiostrongylus vasorum may cause a wide spectrum
of clinical signs. Respiratory distress such as coughing and dyspnoea are the most frequently described manifestations.
The aim of the present study was to gain additional information on the distribution, prevalence and risk factors associated
with A. vasorum infection in dog from southern Belgium through the combined used of a commercially available in-clinic
assay for detection of circulating antigen (Angio Detect™, IDEXX, Westbrook, USA) and coprology in two different canine
populations: dogs with clinical signs compatible with angiostrongylosis and asymptomatic dogs or dogs presented for
unrelated conditions (control).
Results: A total of 979 dogs were enrolled in the study from November 2014 until February 2016. Seven hundred fifty-
seven dogs were included in the control group, whereas 222 dogs had clinical signs compatible with angiostrongylosis.
Forty-six dogs out of 979 (4.7 %) had A. vasorum circulating antigen. There was a highly significant difference between
the two populations (3.6 % (27/747) and 8.6 % (19/222) in control and symptomatic dogs, respectively) (P = 0.00379). First
stage larvae (L1) of A. vasorum were found in seven out of 24 serologically positive control dogs and in six out of 17
serologically positive symptomatic dogs. Interestingly, L1 of Crenosoma vulpis were detected by Baermann technique in
one control and nine symptomatic dogs, respectively. Out of 17 Angio Detect™ (IDEXX, Westbrook, USA) positive dogs
with negative (14) or not performed Baermann test (three), one dog was positive in both in-house ELISAs (Ag and Ab)
and one dog was positive for Ag. Statistical analysis was unable to detect any risk factors associated with the direct and/
or indirect detection of A. vasorum.
Conclusions: This seroepidemiological study demonstrated for the first time a high seroprevalence in Southern Belgium
for A. vasorum. The Angio Detect™ was found to be suitable in this context as the collection, preservation and examination
of stools were difficult. Nevertheless, discrepancies were observed between the different available tests. Additional research
is clearly needed. Also, coproscopy remains a very useful tool in dogs infected for less than nine weeks and for the
identification of other canine lung nematodes such as C. vulpis. This study also demonstrates that asymptomatic dogs may
shed A. vasorum L1 in their faeces and therefore contribute to the maintenance of A. vasorum life-cycle.
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Background
Canine angiostrongylosis, a gastropod-borne helminthic
infection caused by the so-called “French heartworm”,
was first reported in France in the 1800s [1]. The disease
is increasingly being described in North America [2] and
is reported now in many European countries [3]. The
red fox (Vulpes vulpes) is considered as the main reser-
voir of this nematode [4] and many species of slugs and
snails may act as intermediate hosts [5].
In dogs, Angiostrongylus vasorum may cause a wide
spectrum of clinical signs from mild to severe, which can
lead to death. Respiratory distress such as coughing and
dyspnoea are the most frequently described manifesta-
tions. The diagnosis of the disease is sometimes very chal-
lenging as infected animals may exhibit clinical signs
overlapping those of other conditions [6], be atypical such
as bleeding and neurological disorders or be absent [7–9].
Despite the fact that epidemiological models indicate
that Belgium has a highly favourable climate for the
completion of A. vasorum life-cycle [10], the parasite
was not recorded in this country until 2013 when a fatal
autochthonous case was described in a four and a half
month puppy [11]. Very recently, nine additional cases
were diagnosed through Baermann faecal examination and
quantitative PCR on bronchoalveolar lavage fluid [12, 13],
which suggests that the parasite could be well established
in Belgium at least in the study area (Wallonia, southern
Belgium). However, it is well known that A. vasorum has a
patchy distribution [14, 15] and this might be a challenge
for the collection of reliable epidemiological data.
A confirmatory diagnosis can be obtained using the
Baermann method, based on the isolation and micro-
scopic identification of A. vasorum first stage larvae (L1)
from faeces, showing the characteristic notch feature on
the tail [16]. Nevertheless, the availability of newly devel-
oped commercial tests targeting circulating A. vasorum
antigens has made possible the in-clinic diagnosis of this
infection [17], while the ELISAs used for mass-screening
in different canine populations allowed the implementa-
tion of region- or even nation-wide surveys [18–20].
The aim of the present study was to gain additional
information on the distribution, prevalence and risk fac-
tors associated with A. vasorum infection in the dog
through the combined used of in-clinic detection of cir-
culating antigen and of coprology in two different canine
populations: dogs with clinical signs compatible with
angiostrongylosis and asymptomatic dogs or dogs pre-
sented for unrelated conditions.
Methods
Collection of samples and data
The survey was conducted from November 2014 until
February 2016. Seventeen small animal practices were
selected on voluntary basis across Southern Belgium
(Wallonia) (Fig. 1). In each practice samples were col-
lected from dogs belonging to two populations: a first
random dog population (called “control” thereafter) pre-
sented for unrelated conditions (such as vaccination, spay-
ing, traumas, skin conditions and others) whereas the
second population included dogs showing clinical signs
compatible with angiostrongylosis such as coughing,
exercise intolerance, dyspnoea, bleeding or neurological
disorders. Dogs from any breeds, age and sex were in-
cluded in this survey. These two populations were selected
based on the exclusion criteria of absence of travel history
outside Belgium during the three previous months.
Simultaneously, a questionnaire was filled in by the
owner: sex, age, breed, locality, life style and recent anti-
parasitic treatments, if any, were recorded.
Sample analysis
Blood samples from these dogs were collected in dry or
heparinised tubes and centrifuged in order to obtain
serum or plasma. An in-clinic serological test detecting
A. vasorum circulating Ag (Angio Detect™, IDEXX,
Westbrook, USA) was used for initial screening of all
dogs (979) following manufacturer’s instructions, with a
sensitivity of 84.6 % and a specificity of 100 %, as previ-
ously described [17]; reading of the test was performed
strictly at 15 min. Intensity of positive results was
assessed as +, ++, +++ [17]. All practices have been
trained and monitored by the first author in order to
obtain comparable results.
Recently passed stools from dogs with a positive sero-
logical screening were collected on 3 consecutive days.
In some cases, this was not possible, or stools were ob-
tained only once or twice. Additionally, some serologic-
ally negative dogs with a high suspicion of lungworm
infection (showing dyspnoea or coughing or living with
another seropositive dog) were also screened through
coproscopy by isolation of L1 through Baermann larval
migration-technique. This examination was done at the
Laboratory of Parasitology of the Faculty of Veterinary
Medicine, University of Liège. Differentiation between A.
vasorum and C. vulpis L1 was performed based on mor-
phological criteria [21].
Sera presenting conflicting results between serology
and coprology were sent to the Institute of Parasitology,
Vetsuisse Faculty, University of Zurich, Switzerland, and
were further analysed for the presence of circulating
A. vasorum antigens using monoclonal and polyclonal
antibodies in a sandwich-ELISA, with a sensitivity of
95.7 % and a specificity of 94.0 %, as previously de-
scribed [22]. Additionally, a sandwich-ELISA (sensitivity
81.0 %, specificity 98.8 %) using A. vasorum adult somatic
antigen purified by monoclonal antibodies (mAb Av 5/5)
was used for specific antibody detection [23]. All test runs
included a background control, a conjugate control, three
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positive control sera from three experimentally infected
dogs and two negative control sera from uninfected dogs.
Statistical analysis
To identify possible risk factors associated with the sero-
positivity to A. vasorum, answers to the questionnaire
were encoded and merged with the serological results
(positive, negative) of each dog. The host variables were
made available to the model, with sex as a binary variable
(male or female), access to garden, terrace, urban park,
forest, street and vegetable garden as binary variable (yes/
no), housing as a binary variable (inside or access to the
outside), clinical signs compatible with angiostrongylosis
as a binary variable (yes/no), age as a categorical variable
(< 1 year, between 1 and 3 years, between 3 and 8 years
and over 8 years), post code of the owner’s domicile as a
categorical variable and locality as a categorical variable
(urban, rural or periurban).
An univariate analysis was conducted and odds ratio's
(OR) with 95 % confidence intervals (CIs 95 %) were
attributed to each variable. All variables with P < 0.20 in
univariate analysis were then included in subsequent
multivariate logistic regression analyses. A P value < 0.05
was used to define statistical significance.
Statistical analyses were performed using the R software/
environment (R-3.1.2, R Foundation for Statistical Comput-
ing, http://www.r-project.org/) and SAS software, Version
9.3 TS level 1 M2 of the SAS System for Unix and SAS
University Edition (SAS Institute, Cary, NC, USA).
Results
A total of 979 dogs were enrolled in the study. Seven
hundred fifty-seven were included in the control group,
whereas 222 dogs had clinical signs compatible with an-
giostrongylosis. The distribution of samples according to
the different tests (serology versus coprology) is given in
Table 1. Forty-six dogs out of 979 (4.7 %) had A.
vasorum circulating antigen detected with the rapid in-
clinic assay. There was a highly significant difference be-
tween the two populations (3.6 % (27/757) and 8.6 %
(19/222) in control and symptomatic dogs respectively)
(χ2 = 8.4702, df = 1, P = 0.00361).
Stools were obtained from 41 seropositive dogs (24
and 17 in control and symptomatic dogs respectively)
and 6 seronegative dogs with strong suspicion of angio-
strongylosis (1 and 5 in control and symptomatic dogs
respectively). Stools from 5 seropositive dogs were not
available for testing. L1 of A. vasorum were found in 7
out of 24 (29 %) serologically positive (Angio Detect™)
control dogs and in 6 out of 17 (35 %) serologically posi-
tive symptomatic dogs. Interestingly L1 of C. vulpis were
detected by the larval migration Baermann technique in
1 control and 9 symptomatic dogs, respectively. In the
latter group 1 dog was found seropositive for A. vasorum
Fig. 1 Selected veterinary clinics and their locations across southern Belgium
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but only C. vulpis L1 were found, and 1 dog was found
seronegative for A. vasorum but L1 of A. vasorum and C.
vulpis were found via the Baermann technique (Fig. 2). A
majority of seropositive (Angio Detect™) and symptomatic
dogs exhibited cardio-pulmonary symptoms (cough, dys-
pnoea and exercise intolerance). Neurological signs and
bleeding were recorded in one symptomatic dog (Table 2).
Eighteen sera of dogs with conflicting results between
serology and coproscopy (or coproscopy not performed)
were analysed by in-house ELISAs at the Institute of
Parasitology of the University of Zurich, Switzerland.
Out of 17 seropositive dogs with Angio Detect™ and with
negative or not performed Baermann test, one dog was
positive for both ELISAs (Ag and Ab) and one dog was
positive for Ag ELISA only. The dog found seronegative
for A. vasorum with Angio Detect™ but positive for L1 of
A. vasorum and C. vulpis was found positive by Ab
ELISA (Table 3).
Data obtained from the questionnaire provided the differ-
ent localities where dogs were living (Fig. 3). In the univari-
ate analysis access to the forest (Z = -1.673, P = 0.094) and
clinical signs (Z = 2.895, P = 0.00379) were associated with
seropositivity to A. vasorum. These two explanatory vari-
ables were included in the multivariate model. However,
only the presence of clinical signs compatible with angio-
strongylosis resulted as a risk factor for A. vasorum sero-
positivity (P = 0.0079; OR = 3.1; 95 % CI: 1.33–7.22).
Discussion
Originally, three practices were chosen for a pilot study
because of previously diagnosed canine angiostrongylosis
in the region. Additionally, 14 other practices in south-
ern Belgian were enrolled in the study based on the
interest they showed to test and deliver samples in order
to explore whether more cases could be diagnosed. The
implementation of this type of survey relies heavily on
the willingness and rigour of the different participants,
Fig. 2 First stage larvae of Crenosoma vulpis (left) and Angiostrongylus
vasorum (right) found in faeces of a dog isolated by the Baermann
method
Table 2 Number of dogs showing different clinical signs
recorded by the veterinarians in the questionnaire
Clinical signs Dogs Angio Detect™-positive
Coughing 86 6
Dyspnoea 19 3
Exercise intolerance 39 3
Bleeding 11 1
Neurological disorders 13 1
Coughing + exercise intolerance 44 5
Coughing + bleeding 6 0
Bleeding + neurological disorders 1 0
No clear statement 3 0
Total 222 19
Table 1 Results of Angio Detect™ (IDEXX, Westbrook, USA) rapid assay test performed with sera of symptomatic and control dogs.
Baermann coprological analysis was performed on dogs positive for Angio Detect™ test or suspected of angiostrongylosis
Parasite Control dogs
n = 757 (%)
Symptomatic dogs
n = 222 (%)
Total
n = 979 (%)
Total Angio Detect™-positive 27/757 (3.6) 19/222 (8.6) 46/979 (4.7)
Angio Detect™-positive and
Baermann not performed
3/27 2/19 5/46
Angio Detect™-positive and
Baermann-positive
L1 A. vasorum 7/24 (29) 6/17 (35) 13/41 (32)
L1 C. vulpis 0/24 1/17 1/41
L1 A. vasorum and C. vulpis 0/24 2/17 2/41
Angio Detect™-positive and
Baermann-negative
17/24 8/17 25/41
Angio Detect™-negative and
Baermann-positive
L1 A. vasorum 0/1 0/5 0/6
L1 C. vulpis 1/1 4/5 5/6
L1 A. vasorum and C. vulpis 0/1 1/5 1/6
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namely the veterinary practices. This may be considered
as a potential bias. However, canine practices were se-
lected in the five different provinces of southern Belgium
(Wallonia) where a large number of both symptomatic
and control dogs were sampled. Therefore, the present
survey, the first large scale epidemiological study con-
ducted in Belgium, should be considered as a pilot
study aiming to give a fairly good estimation of the
impact of angiostrongylosis in the canine population
of southern Belgium.
For practical reasons (ease of use and rapidity) the 979
canine sera were screened using an in-clinic test (Angio
Detect™) which is able to detect specific A. vasorum circu-
lating antigen as early as nine weeks post-experimental in-
oculation. This test has a good sensitivity (84.6 %) for
clinically affected dogs, and a very high specificity (100 %)
regarding different lungworms [17]. In total 46 dogs (4.7 %)
had specific circulating antigen which indicates that A.
vasorum infections is well established in the canine south-
ern Belgian population. This is in agreement with recently
published data dealing with single case reports [11, 13] or
small clinical series [12]. Large-scale seroepidemiological
surveys were previously performed in Europe using ELISAs,
showing antigen detection in 0.5 to 2.17 % of the study
populations [18–20, 24–26]. Among Belgium’s neighbour-
ing countries, in Germany, 4003 randomly selected canine
sera were collected from western federal states and tested
by Schnyder et al. [18] using Ab and Ag ELISAs, the latter
test being able to detect A. vasorum specific antigen as early
as seven weeks post-infection [27]. A total of 20 sera
Table 3 Results of in-house ELISAs (Ag and Ab) tested on 18 dogs with conflicting results between serology and coprology (negative)
or with coprology not performed
Angio Detect™-positive Angio Detect™-negative
ELISA Ag ELISA Ab ELISA Ag ELISA Ab
No. positive/
No. tested)
No. negative/
No. tested
No. positive/
No. tested
No. negative/
No. tested
No. positive/
No. tested
No. negative/
No. tested
No. positive/
No. tested
No. negative/
No. tested
Symptomatic 1/4 3/4 1/4 3/4 0/1 1/1 1/1 0/1
Control 1/13 12/13 0/13 13/13 – – – –
Total 2/17 15/17 1/17 16/17 0/1 1/1 1/1 0/1
Fig. 3 Locations (based on postal codes) of seropositive dogs for A. vasorum according to Angio Detect™ (IDEXX, Westbrook, USA) and C. vulpis
according to Baermann examination in southern Belgium
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(0.5 %) were antigen positive in that study. The comparison
of this seroprevalence with the results of the control group
presented in our study (3.6 %) confirms that the investi-
gated area, which has a border with North Rhine Westphal
and Rhineland-Palatinate must be very suitable for the
completion of A. vasorum life-cycle [10], particularly con-
sidering that the rapid in-clinic assay is recommended for
testing clinically affected dogs and less sensitive than the
ELISAs that have been used in the mentioned study from
Germany. In symptomatic dogs the proportion of antigen
positive dogs was even higher (8.6 %). The majority of these
dogs had cardio-pulmonary symptoms (cough, dyspnoea,
exercise intolerance) which are by far the most commonly
observed clinical signs in dogs with canine angiostrongylo-
sis [9]. Coagulopathies and neurological disorders, which
were only reported in one seropositive dog during the
present study, are reported in canine angiostrongylosis but
represent a small proportion of the patients [7].
Other epidemiological studies based on coproscopy
confirmed that asymptomatic dogs can excrete L1 and
thus contribute to the dissemination of the parasite in
the environment. For example, in UK, Morgan et al. [28]
found A. vasorum L1 in the faeces of 15 % and 2 % of
symptomatic and asymptomatic dogs, respectively. Bar-
utzki & Schaper [29] in Germany isolated L1 in 6 % of
symptomatic dogs (n = 810) versus 0.1 % in a survey
conducted earlier by the same authors in asymptomatic
individuals [30]. It is not known whether these asymp-
tomatic carriers may or may not develop clinical signs
later on, as the majority of these dogs may have been
treated with an anthelmintic drug.
The larval migration-technique was difficult to imple-
ment during this study: a total of 47 stool samples were ob-
tained and in some cases, samples from only one day of
collection were provided by the owners, or the stools had
dried up. This might explain at least partly the high level of
discrepancy observed between the serological assay (positiv-
ity) and the Baermann technique (negativity). Additional
explanations could be linked to the technical characteristics
of the in-clinic test which requires reading after 15 min
sharp (and resulting in false positive results if reading is
performed later), and the potential of non-reported anti-
parasitic treatment by the owner (resulting in negative
coproscopy while serology may still be positive) [27].
Indeed, in experimentally infected dogs, patency started be-
tween 7–8 weeks after infection, approximately at the same
time of antigen detection (while antibody detection may
start as soon as three weeks after infection), with the differ-
ence that dogs, once diagnosed seropositive, remain
positive unless treated [27], in opposition to Baermann
examination, where intermittent larval shedding can be ob-
served [31]. The potential role of the immune response that
inhibits the production of L1 as described in canine dirofi-
lariosis [32] could also be hypothesised. Nevertheless, some
discrepancies were not explained by the above hypotheses
and some dogs positive with Angio Detect™ were not con-
firmed by in house ELISAs (Ag and/or Ab).
Interestingly, L1 of C. vulpis were observed in nine and
one symptomatic and control dogs, respectively confirm-
ing the presence of this nematode in Belgium, as recently
reported [33]. Consequently, this parasitic infection must
be included in the differential diagnosis of pulmonary con-
ditions. It is noteworthy that in five of these C. vulpis in-
fected dogs the Angio Detect™ assay resulted in a negative
result, while a mixed infection in these dogs may have
been missed. This confirmed the high specificity of the
test as previously demonstrated by Schnyder at al. [20] to-
wards C. vulpis and other canine nematodes. In one symp-
tomatic Angio Detect™ negative dog, L1 of both A.
vasorum and C. vulpis were observed, whereas the sample
was found to be positive with Ab ELISA. A possible ex-
planation could be the production of immune complexes,
as shown for Dirofilaria immitis, which could block Ag
detection on commercially available tests [34, 35].
Conclusions
In conclusion, this seroepidemiological study demon-
strated a high seroprevalence in southern Belgium for A.
vasorum and further investigation is necessary to check
if this patchy distribution in the investigated area is also
present in the northern part of Belgium. The Angio
Detect™ was found to be suitable in this context as the
collection, preservation and examination of stools were
challenging. More research is needed in order to under-
stand variability in the results obtained from different
diagnostic tools. However, coproscopy remains a very
useful tool in patent dogs infected for less than nine
weeks and for the identification of other canine lung
nematodes such as C. vulpis as mixed infections with
different lungworm species may occur. This study also
demonstrates that asymptomatic dogs or dogs presented
for unrelated conditions may shed A. vasorum L1 in
their faeces and therefore contribute to the maintenance
of A. vasorum life-cycle. Consequently, practitioners in
endemic areas should be sensitized and may suggest to
screen for A. vasorum infection even in asymptomatic
dogs. For dogs with eating behaviour at high-risk and
potential ingestion of snails, regular testing or preventa-
tive monthly treatments are recommended [36].
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